Simon Ekman

488 total citations
12 papers, 293 citations indexed

About

Simon Ekman is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Oncology. According to data from OpenAlex, Simon Ekman has authored 12 papers receiving a total of 293 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 3 papers in Endocrinology, Diabetes and Metabolism and 2 papers in Oncology. Recurrent topics in Simon Ekman's work include PI3K/AKT/mTOR signaling in cancer (5 papers), Protein Kinase Regulation and GTPase Signaling (3 papers) and Growth Hormone and Insulin-like Growth Factors (3 papers). Simon Ekman is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (5 papers), Protein Kinase Regulation and GTPase Signaling (3 papers) and Growth Hormone and Insulin-like Growth Factors (3 papers). Simon Ekman collaborates with scholars based in Sweden, Russia and Finland. Simon Ekman's co-authors include Lars Rönnstrand, Carl‐Henrik Heldin, Michael Bergqvist, Ulf Hellman, Stefan Bergström, Ulla Engström, Johan Harmenberg, Anders Kallin, Irina Alafuzoff and Anja Smits and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Oncogene.

In The Last Decade

Simon Ekman

12 papers receiving 289 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simon Ekman Sweden 9 180 69 49 43 39 12 293
Estelle Daudigeos‐Dubus France 11 161 0.9× 102 1.5× 72 1.5× 58 1.3× 16 0.4× 19 332
Cláudia Miranda Italy 11 223 1.2× 143 2.1× 52 1.1× 18 0.4× 92 2.4× 15 411
Emanuela Roccato Italy 8 180 1.0× 134 1.9× 49 1.0× 21 0.5× 74 1.9× 8 363
Ilsa Coleman United States 5 203 1.1× 116 1.7× 70 1.4× 19 0.4× 31 0.8× 7 433
Daniela R. Macció Argentina 9 185 1.0× 158 2.3× 59 1.2× 13 0.3× 21 0.5× 10 373
Daniel Antunes Moreno Brazil 11 293 1.6× 87 1.3× 73 1.5× 82 1.9× 10 0.3× 34 461
Chia-Ing Jan Taiwan 7 207 1.1× 140 2.0× 101 2.1× 52 1.2× 14 0.4× 9 383
Imke Beier Germany 8 165 0.9× 112 1.6× 51 1.0× 41 1.0× 8 0.2× 12 371
Wanglong Deng China 9 136 0.8× 110 1.6× 119 2.4× 21 0.5× 37 0.9× 29 347
Cinthia Amiñoso Spain 12 233 1.3× 62 0.9× 79 1.6× 101 2.3× 15 0.4× 18 409

Countries citing papers authored by Simon Ekman

Since Specialization
Citations

This map shows the geographic impact of Simon Ekman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Ekman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Ekman more than expected).

Fields of papers citing papers by Simon Ekman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Ekman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Ekman. The network helps show where Simon Ekman may publish in the future.

Co-authorship network of co-authors of Simon Ekman

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Ekman. A scholar is included among the top collaborators of Simon Ekman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Ekman. Simon Ekman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
2.
Ekman, Simon, Johan Harmenberg, Jan‐Erik Frödin, et al.. (2015). A novel oral insulin-like growth factor-1 receptor pathway modulator and its implications for patients with non-small cell lung carcinoma: A phase I clinical trial. Acta Oncologica. 55(2). 140–148. 17 indexed citations
3.
Libard, Sylwia, Svetlana N. Popova, Rose‐Marie Amini, et al.. (2014). Human Cytomegalovirus Tegument Protein pp65 Is Detected in All Intra- and Extra-Axial Brain Tumours Independent of the Tumour Type or Grade. PLoS ONE. 9(9). e108861–e108861. 41 indexed citations
4.
Elsir, Tamador, Per‐Henrik Edqvist, Joseph W. Carlson, et al.. (2013). A study of embryonic stem cell‐related proteins in human astrocytomas: Identification of Nanog as a predictor of survival. International Journal of Cancer. 134(5). 1123–1131. 41 indexed citations
5.
Wu, Xuping, Linda Sooman, Johan Lennartsson, et al.. (2012). Microtubule inhibition causes epidermal growth factor receptor inactivation in oesophageal cancer cells. International Journal of Oncology. 42(1). 297–304. 14 indexed citations
6.
Johansson, Fredrik, Simon Ekman, Erik Blomquist, et al.. (2012). A review of dose-dense temozolomide alone and in combination with bevacizumab in patients with first relapse of glioblastoma.. PubMed. 32(9). 4001–6. 7 indexed citations
7.
Ekman, Simon, Johan Harmenberg, Jan‐Erik Frödin, et al.. (2012). A novel targeted oral insulin-like growth factor-1 receptor (IGF-1R) inhibitor and its implications for patients with non-small cell lung cancer (NSCLC): A phase I clinical trial.. Journal of Clinical Oncology. 30(15_suppl). 7539–7539. 2 indexed citations
8.
Ekman, Simon, Jan‐Erik Frödin, Johan Harmenberg, et al.. (2010). Clinical Phase I study with an Insulin-like Growth Factor-1 Receptor Inhibitor: Experiences in patients with squamous non-small cell lung carcinoma. Acta Oncologica. 50(3). 441–447. 41 indexed citations
9.
Wu, Xinhua, Lars Gedda, Alkwin Wanders, et al.. (2008). 154 POSTER Hsp90 is expressed and represents a novel target in human oesophageal cancer using the inhibitor 17-allylamino-17-demethoxy- geldanamycin. European Journal of Cancer Supplements. 6(12). 49–50. 1 indexed citations
10.
Demoulin, Jean‐Baptiste, Jeong Kon Seo, Simon Ekman, et al.. (2003). Ligand-induced recruitment of Na+/H+-exchanger regulatory factor to the PDGF (platelet-derived growth factor) receptor regulates actin cytoskeleton reorganization by PDGF. Biochemical Journal. 376(2). 505–510. 39 indexed citations
11.
Ekman, Simon, Anders Kallin, Ulla Engström, Carl‐Henrik Heldin, & Lars Rönnstrand. (2002). SHP-2 is involved in heterodimer specific loss of phosphorylation of Tyr771 in the PDGF β-receptor. Oncogene. 21(12). 1870–1875. 36 indexed citations
12.
Hellman, Ulf, et al.. (1998). Identification of Tyr-762 in the platelet-derived growth factor α-receptor as the binding site for Crk proteins. Oncogene. 16(10). 1229–1239. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Estelle Daudigeos‐Dubus Breakdown of academic impact, for papers by Cláudia Miranda Breakdown of academic impact, for papers by Emanuela Roccato Breakdown of academic impact, for papers by Ilsa Coleman Breakdown of academic impact, for papers by Daniela R. Macció Breakdown of academic impact, for papers by Daniel Antunes Moreno Breakdown of academic impact, for papers by Chia-Ing Jan Breakdown of academic impact, for papers by Imke Beier Breakdown of academic impact, for papers by Wanglong Deng Breakdown of academic impact, for papers by Cinthia Amiñoso
Rankless by CCL
2026